Resectability and resection rates of colorectal liver metastases according to <i>RAS</i> and <i>BRAF</i> mutational status: prospective study-Reference-Cited by-同舟云学术

Resectability and resection rates of colorectal liver metastases according to RAS and BRAF mutational status: prospective study

Published:2022-12-13 Issue: Volume: Page:
ISSN:0007-1323
Container-title:British Journal of Surgery
language:en
Short-container-title:

Author:

Uutela Aki¹²^ORCID,Nordin Arno¹,Osterlund Emerik¹³,Halonen Päivi⁴,Kallio Raija⁵,Soveri Leena-Maija⁶⁷,Salminen Tapio⁸,Ålgars Annika⁹,Ristimäki Ari¹⁰,Ovissi Ali¹¹,Lamminmäki Annamarja¹²,Muhonen Timo⁷¹³,Kononen Juha¹⁴¹⁵,Ristamäki Raija⁹,Heervä Eetu⁹,Stedt Hanna¹²,Lehtomäki Kaisa⁸,Kytölä Soili¹⁶,Sundström Jari¹⁷,Mäkinen Markus J¹⁸,Nieminen Lasse¹⁹,Kuopio Teijo²⁰,Keinänen Mauri²¹,Osterlund Pia⁴⁸²²,Isoniemi Helena¹^ORCID,Mäkisalo Heikki,Huuhtanen Riikka,Lantto Eila,Kosunen Juhani,Leppä Sirpa,Bono Petri,Mattson Johanna,Räsänen Jari,Lepistö Anna,Penttinen Heidi,Mäkelä Siru,Carpén Olli,Lundbom Nina,Hakkarainen Antti,Timonen Marjut,Salminen Veera,Paunu Niina,Rinta-Kiikka Irina,Vornanen Martine,Virtanen Johanna,Korkeila Eija,Sutinen Eija,Lavonius Maija,Sundström Jari,Blanco Roberto,Pääkkö Eija,Tuomisto-Huttunen Tiina,Auvinen Päivi,Kärjä Vesa,Kainulainen Sakari,Kettunen Hannu-Pekka,Kellokumpu Ilmo,Aarnio Markku,Väyrynen Ville,Vasala Kaija,Ketola Sanna,Nuorva Kyösti,Murashev Maija-Leena,Pulkkanen Kalevi,Viitanen Venla,Nieppola Marko,Haalisto Elina,Nyandoto Paul,Aalto Aino,Ala-Luhtala Timo,Tuominiemi Jukka,Sainast Anneli,Pusa Laura,Kosonen Sanna,Helle Leena,Hermansson Terhi,Kokko Riitta,Aroviita Laura,Nokisalmi Petri,Sailas Liisa,Tokola Heikki,Jekunen Antti,Pöytäkangas Teemu,Möykkynen Kari,Kosonen Sanna,Isokangas Olli-Pekka,Vaarala Svea,Klaavuniemi Tuula,Kolle Rainer,Karihtala Peeter,Heikkinen Mirja,Johansson Kaisu,Sjöstrand Anna,Kajasviita Piia,Kaleva-Kerola Jaana,Männistö Esa,Lindvall-Andersson Reneé,Kaunismaa Tom,Vihinen Pia,Cavalli-Björkman Nina,

Affiliation:

1. Department of Transplantation and Liver Surgery, Abdominal Centre, Helsinki University Hospital and University of Helsinki , Helsinki , Finland

2. Department of Transplant and Hepatopancreatobiliary Surgery, Royal Infirmary of Edinburgh , Edinburgh , UK

3. Department of Immunology, Genetics and Pathology, Uppsala University , Uppsala , Sweden

4. Department of Oncology, Helsinki University Hospital Comprehensive Cancer Centre and University of Helsinki , Helsinki , Finland

5. Department of Oncology, Oulu University Hospital , Oulu , Finland

6. Home Care Geriatric Clinic and Palliative Care, Joint Municipal Authority for Health Care and Social Services in Keski-Uusimaa , Hyvinkää , Finland

7. Faculty of Medicine, University of Helsinki , Helsinki , Finland

8. Department of Oncology, Tampere University Hospital and University of Tampere , Tampere , Finland

9. Department of Oncology, Turku University Hospital and University of Turku , Turku , Finland

10. Department of Pathology, HUS Diagnostic Centre and Applied Tumour Genomics, Research Programmes Unit, Helsinki University Hospital and University of Helsinki , Helsinki , Finland

11. Department of Radiology, HUS Medical Imaging Centre, Helsinki University Hospital and University of Helsinki , Helsinki , Finland

12. Department of Oncology, Kuopio University Hospital and University of Eastern Finland , Kuopio , Finland

13. Department of Oncology, South Carelia Central Hospital , Lappeenranta , Finland

14. Department of Oncology, Central Finland Hospital Nova , Jyväskylä , Finland

15. Docrates Cancer Center , Helsinki , Finland

16. Department of Genetics, HUSLAB, HUS Diagnostic Centre, Helsinki University Hospital and University of Helsinki , Helsinki , Finland

17. Department of Pathology, Turku University Hospital and University of Turku , Turku , Finland

18. Department of Pathology, Oulu University Hospital and University of Oulu , Oulu , Finland

19. Department of Pathology, Tampere University Hospital and University of Tampere , Tampere , Finland

20. Department of Pathology, Central Finland Central Hospital , Jyväskylä , Finland

21. Department of Genetics, FIMLAB laboratories, Tampere University Hospital , Tampere , Finland

22. Department of Oncology/Pathology, Karolinska Institutet and Karolinska Sjukhuset, Cancer Centre of Excellence , Stockholm , Sweden

Funder

Finska Läkaresällskapet

Cancer Foundation Finland

Relander’s Foundation

Tampere University Hospital Funds

Helsinki University Hospital

Publisher

Oxford University Press (OUP)

Subject

Surgery

Link

https://academic.oup.com/bjs/advance-article-pdf/doi/10.1093/bjs/znac424/47831390/znac424.pdf

Reference20 articles.

1. Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates;Folprecht;Ann Oncol,2005

2. Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trial;Gruenberger;Ann Oncol,2015

3. Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study group;Modest;Ann Oncol,2016

4. High BRAF mutation frequency and marked survival differences in subgroups according to KRAS/BRAF mutation status and tumor tissue availability in a prospective population-based metastatic colorectal cancer cohort;Sorbye;PLoS One,2015

5. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up;Cervantes;Ann Oncol,2022

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatectomy versus systemic therapy for liver-limited BRAF V600E-mutated colorectal liver metastases: multicentre retrospective study;British Journal of Surgery;2024-07

2. Impact of Primary Tumor Location on Demographics, Resectability, Outcomes, and Quality of Life in Finnish Metastatic Colorectal Cancer Patients (Subgroup Analysis of the RAXO Study);Cancers;2024-03-05

3. The Importance of Optimal Thermal Ablation Margins in Colorectal Liver Metastases: A Systematic Review and Meta-Analysis of 21 Studies;Cancers;2023-12-12